The Vanguard Group Discloses Stake in Spire Healthcare

The Vanguard Group, Inc. released a Form 8.3 disclosure, confirming its interest in Spire Healthcare Group plc. As of March 24, 2026, Vanguard controls 3.60% of Spire's 1p ordinary shares, totaling 14,479,506 shares. This information was shared as per Rule 8.3 of the Takeover Code, which mandates disclosures for interests representing 1% or more of relevant securities.

Additionally, Vanguard executed a sale of 3,404 of these 1p ordinary shares at 1.43 GBP per share. No cash-settled or stock-settled derivatives were disclosed, and there are no reported indemnity or option arrangements or agreements relating to voting rights. The disclosure does not include any supplemental open position forms. This recent disclosure may interest stakeholders monitoring changes in ownership and positions within Spire Healthcare.